Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.6_suppl.633
Abstract: 633Background: DFS has been frequently used as endpoint in the adjuvant setting and was the primary basis of approval for adjuvant cancer therapies. In S-TRAC, adjuvant sunitinib demonstrated a sig...
read more here.
Keywords:
trial sensitivity;
analyses disease;
trac trial;
sensitivity analyses ... See more keywords